Your browser doesn't support javascript.
loading
Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify.
Johnson, Philip J; Innes, Hamish; Hughes, David M; Kalyuzhnyy, Anton; Kumada, Takashi; Toyoda, Hidenori.
Afiliação
  • Johnson PJ; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK. Philip.Johnson@liverpool.ac.uk.
  • Innes H; School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.
  • Hughes DM; Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK.
  • Kalyuzhnyy A; Public Health Scotland, Glasgow, UK.
  • Kumada T; Department of Health Data Science, University of Liverpool, Liverpool, UK.
  • Toyoda H; Computational Biology Facility, University of Liverpool, Liverpool, UK.
Br J Cancer ; 127(7): 1263-1269, 2022 10.
Article em En | MEDLINE | ID: mdl-35798825
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido